Rationale and study design of a randomized controlled trial to assess the effects of maintaining hemoglobin levels using darbepoetin alfa on prevention of development of end-stage kidney disease in non-diabetic CKD patients (PREDICT Trial)
暂无分享,去创建一个
M. Nangaku | I. Narita | S. Morita | H. Hirakata | T. Akizawa | E. Imai | S. Maruyama | Terumasa Hayashi | Y. Tsubakihara | E. Nakatani | H. Kono